Anders Lonnqvist - STRAX AB Independent Director
| NOBC Stock | EUR 0.01 0 11.90% |
Insider
Anders Lonnqvist is Independent Director of STRAX AB SK since 2011.
| Age | 59 |
| Tenure | 13 years |
| Phone | 46 8 54 50 17 50 |
| Web | http://www.strax.com |
STRAX AB Management Efficiency
STRAX AB's management efficiency ratios could be used to measure how well STRAX AB manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Supawan Sirinuntawit | Bumrungrad Hospital Public | N/A | |
| Aniello Sorrentino | Bumrungrad Hospital Public | 76 | |
| Ash Jokhoo | Direct Line Insurance | N/A | |
| Daniel Kastner | Bumrungrad Hospital Public | N/A | |
| Paul Smith | Direct Line Insurance | N/A | |
| Jade Trimbee | Direct Line Insurance | N/A | |
| Jessie Burrows | Direct Line Insurance | N/A | |
| Martin Hughes | The Hanover Insurance | 69 | |
| Jeremy Ford | Bumrungrad Hospital Public | N/A | |
| Neil Manser | Direct Line Insurance | 49 | |
| P Condron | The Hanover Insurance | 73 | |
| Oraphan Buamuang | Bumrungrad Hospital Public | 49 | |
| Gayle Falvey | The Hanover Insurance | N/A | |
| Denise Lowsley | The Hanover Insurance | 47 | |
| Artirat Charukitpipat | Bumrungrad Hospital Public | 55 | |
| Lindsay Greenfield | The Hanover Insurance | N/A | |
| Theodore Bunting | The Hanover Insurance | 60 | |
| Willard Lee | The Hanover Insurance | 53 | |
| Scott Grieco | The Hanover Insurance | N/A | |
| David FACHE | Bumrungrad Hospital Public | N/A | |
| Linda Lisahapanya | Bumrungrad Hospital Public | 70 | |
Management Performance
| Return On Equity | -0.53 | |||
| Return On Asset | 0.0093 |
STRAX AB SK Leadership Team
Elected by the shareholders, the STRAX AB's board of directors comprises two types of representatives: STRAX AB inside directors who are chosen from within the company, and outside directors, selected externally and held independent of STRAX. The board's role is to monitor STRAX AB's management team and ensure that shareholders' interests are well served. STRAX AB's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, STRAX AB's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Bertil Villard, Independent Chairman of the Board | ||
| Simon Neave, Global Sales Director ROW | ||
| Anders Lonnqvist, Independent Director | ||
| Phil Mulholland, Chief Marketing Officer | ||
| Pia Anderberg, Director | ||
| Johan Heijbel, Chief Financial Officer | ||
| Ingvi Tomasson, Founder, Director | ||
| Frank Hackmann, Global Sales Director DACH, NL & PL | ||
| Gudmundur Palmason, Chief Executive Officer, Director |
STRAX Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is STRAX AB a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.53 | |||
| Return On Asset | 0.0093 | |||
| Profit Margin | (0.06) % | |||
| Operating Margin | 0.01 % | |||
| Shares Outstanding | 120.59 M | |||
| Shares Owned By Insiders | 87.10 % | |||
| Shares Owned By Institutions | 1.03 % | |||
| Price To Earning | 61.33 X | |||
| Revenue | 141.82 M | |||
| Gross Profit | 18.64 M |
Currently Active Assets on Macroaxis
Other Information on Investing in STRAX Stock
STRAX AB financial ratios help investors to determine whether STRAX Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in STRAX with respect to the benefits of owning STRAX AB security.